Health

American Researchers Develop Experimental Model to Study Dengue Serotype 4

18 November 20265 min read

American Researchers Develop Experimental Model to Study Dengue Serotype 4
Researchers at the University of Maryland School of Medicine have developed a model for studying dengue serotype 4 infection and monitoring the immune…

Researchers at the University of Maryland School of Medicine in the United States have developed a new experimental model that allows the study of infection with dengue virus serotype 4 and the monitoring of the immune system's response to it. The model helps facilitate the testing of potential vaccines and drugs, and speeds up research aimed at preventing and treating the disease.

The scientific website Medical Xpress reported yesterday, Tuesday, that the results of the study, published in The Lancet Microbe on 29 October, allow researchers to study the immune system's response to this viral type under controlled clinical conditions, and to test the effectiveness of candidate vaccines and treatments before moving on to broader clinical trials.

Study Details

The study was conducted at the University of Maryland School of Medicine in the city of Baltimore, between April 2022 and December 2023, with the participation of 14 healthy adult volunteers. Each received a low dose of the virus by subcutaneous injection, and they were placed under daily medical monitoring with regular blood tests to track the progression of the infection and its accompanying symptoms.

Results

The results showed that all participants were infected with the virus and developed mild to moderate symptoms, most notably rash, fatigue and headache, which allowed the researchers to follow the virus's activity and the immune responses from the earliest stages of infection.

Immunological and genomic analyses revealed strong antibody responses and an increase in the number of antibody-producing cells, along with activation of antiviral genes. The results also showed that the initial infection gave participants immune protection specific to serotype 4 that lasted at least one year, with a marked decrease in immune responses upon subsequent exposure to the virus, indicating acquired immunity against it.

Importance of the Model

The importance of the new model lies in the fact that the dengue virus has four different serotypes, and infection with one of them usually provides long-term immunity against it, but does not guarantee protection against the others. Serotype 4 poses a challenge for researchers because of its intermittent and unpredictable spread, which makes it difficult to assess the effectiveness of vaccines targeting it through large-scale field studies.

The researchers noted that this model complements earlier scientific efforts to develop similar models for serotypes 1 and 3, providing research tools that help study the different types of the virus and evaluate potential vaccines and treatments against it.

Dengue fever is a viral disease that poses a global health challenge. It is transmitted to humans through the bites of infected mosquitoes, and no specific antiviral treatment is available so far. This makes the development of effective vaccines, the strengthening of preventive measures, and the control of mosquito vectors essential means of limiting the spread of the disease and its complications.

Source: Syrian Arab News Agency (SANA)

Comments (0)

0 / 600
No comments yet. Be the first to comment.